chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme  nausea, and diarrhea. with sweats and dizziness for approx 1 hour.  Followed by  2  hours of chills.
The same day that I got my vaccine also received Hep A + Hep B TWINRIX as listed above. I received the shot on the 27 and was told wait 15 minutes. Did without issue. Went home and then worked for part of the day. I started getting normal symptoms fatigue headaches had to leave 3 hours after coming back to work. I expected these symptoms but after eating dinner I started to notice arrhythmia. It felt like a hiccup, but it didn't involve my lungs. I didn't do anything then because I didn't think it was a huge issue and my father is a doctor. So no major concern and went to bed. The very next day I used heart rate reader, noticed I was skipping a heartbeat. After realizing the issue, I called my doctor and she gave me an appointment for Friday. I continued to check it with the reader, and I was able to confirm the arrhythmia would happened right after eating and last 5-45 min. Friday was a remote visit and I showed the Dr. my heartrate reader and did a live reader and I told her all the findings. The next week, I was asked to come in to do a EKG was normal. They also did a 15 min monitoring of my heart and it was fine but she did say she wanted to get updates of everything schedule an heart ultrasound which couldn't be done the same day because of the equipment. Beyond the ultrasound my doctor told me to drink plenty of water and that heart anthemia isn't life threaten. The symptoms continued for another week which would've been two weeks after the shot and then it stopped.
Diarrhea, chills, swollen lymphoma node, chills, body aches fever, eyeballs hurt when moving them, tiredness, muscle and joint pain, sweating, weakness and confusion.
pt recv vax 1245PM on 11OCT96 & @ 245PM on 11OCT96 pt c/o tightness in chest/weak/dizzy/extremities tingling & numb feeling;taken to ER via ambulance-recv 02 & IV;
Pt presented to Recruit Sick Call with c/o neuro deficits (numbness and tingling in fingers and toes) x 3 days. Pt examined and instructed to return for f/u next day. Pt returned with new c/o of difficulty controlling lower extremeties. Pt transferred to ER and then transferred to ICU where he remains at this time.
Information has been received from a pharmacist concerning an adult patient who was inadvertently vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) due to human error. It is unknown if medical attention was sought. The patient's recovery status is unknown. No product quality complaint reported. Additional information has been requested.
Very tired; sore left arm; bone/muscle aches for first day and a half; bone/muscle aches for first day and a half; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 18Apr2021 at 16:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism from an unspecified date. Concomitant medications included liothyronine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), and iron (MANUFACTURER UNKNOWN) 25 mg all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 16:15 the patient experienced very tired, sore left arm, random bone/muscle aches for first day and a half. The clinical outcome of the events tiredness, pain in arm, bone pain, muscle pain was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Patient was suppose to receive DAPTACEL, ACTHIB, and PREVNAR 13, but instead received PENTACEL, ACTHIB, and PREVNAR 13, with no reported adverse event; received two doses of ACTHIB and an extra dose of IPV component, with no adverse event; Initial information received on 04-Oct-2021 regarding an unsolicited valid non-serious case from nurse, consumer/non-healthcare professional and physician via Media Information (under reference 00796837).  This case involves a 17 months old female patient who was suppose to receive DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (DAPTACEL), HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), but instead received DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE [PENTACEL (VERO)], ACT-HIB and PREVNAR 13 (wrong product administered) and received two doses of ACT-HIB and an extra dose of ipv component [extra dose administered].  The patient's past vaccination(s) included IPV (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination. The IPV series was completed in September 2020.  The patient's medical history, past medical treatment(s) and family history were not provided.  On 04-Oct-2021, the patient received concomitant medication, PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) [lot number and expiration date were not reported] via unknown route in an unknown administration site for prophylactic vaccination.  On 04-Oct-2021, the patient received a 0.5 mL fourth dose of suspect PENTACEL (VERO) (Total, lot UJ416AAA and expiration date: 12-Mar-2022) via intramuscular route in the right thigh and on the same day, she received a dose of suspect ACT-HIB (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  It was an actual medication error due to wrong vaccine administered and extra dose administered (same day latency).  It was reported "Nurse would like safety information of receiving extra doses and would like to know how this affects the patients booster dose of IPOL?"  At time of reporting, no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for the suspects DAPTACEL and ACT-HIB.
No additional adverse events.; patient received VAQTA pediatric dose instead of adult dose; patient received VAQTA pediatric dose instead of adult dose; This spontaneous report was received from a nurse referring to a patient of unknown age. Information about medical history, concurrent conditions and concomitant therapies was not provided.     On 12-NOV-2019, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (lot # S021092 and expiration date 18-MAY-2020; dose and route were not provided) pediatric dose instead of adult dose for prophylaxis (incorrect dose administered and product administered to patient of inappropriate age). No additional adverse events.
Achy pain in arm, tightness in bicep, pain underneath arm, under arm swollen with a knot, unable to stretch arm
09/03/2003: Immunizations (DTAP only) on 09/09/2003.  Seen for eyrthema multiforme.
This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (Delayed injection site reaction), PAIN IN EXTREMITY (Arm Sore), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps) and VACCINATION SITE INDURATION (Injection site induration) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm Sore). On 06-Jan-2021, the patient experienced VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen). On 07-Jan-2021, the patient experienced MASS (Blister like bumps). On 08-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm). In January 2021, the patient experienced VACCINATION SITE INDURATION (Injection site induration). On 29-Dec-2020, PAIN IN EXTREMITY (Arm Sore) had resolved. At the time of the report, VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps), VACCINATION SITE INDURATION (Injection site induration), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Body temperature: 99.3 Temp 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Received flu shot in Left arm and did not feel anything so very surprised to next get TDAP in Right arm and immediately experience "fireworks" pain at injection site radiating down arm. Looked at needle as it was withdrawn and appeared longer than expected (I used to be a nurse). Pharmacy tech said I could go but was nervous to leave store so walked around and felt my right arm grow heavy and difficult to raise. Eventually drove home using left arm to steer. Took tylenol with little result. Following day called pharmacy who said DTAP is known to be uncomfortable and they "never use needles longer than 1 inch." By Wed 9/23 arm was not improving so called insurance advice nurse who said go to urgent care but declined to avoid unnecessary covid exposure. She said to wear arm sling and use Voltaren gel because I cannot tolerate NSAIDS. Following morning I had a virtual appointment with my primary care physician who said to minimize use of sling to avoid frozen shoulder, keep using Voltaren and ask physical therapist currently treating me for rehab post back surgery 6/2020 to add shoulder exercises, and let her know if still not better in 4 weeks at which time she would refer me to Physical Medicine specialist for nerve testing. I found I had to wear sling at work (part time librarian) but was able to get by at home without it. By 4 weeks the pain and limited range of motion was improving, by then I could drive and dress myself, but it took a further 2-3 weeks to resolve fully. Primary care physician at checked with immunizations clinic supervisor who asked if the pharmacy tech had been standing (and if I were sitting) for the injection. Yes to both. Immunization clinic chief said this (bad) practice can sometimes direct the needle into the nerve or joint capsule, which may have happened in my case.  If you happen to follow this up with the pharmacy please note their paperwork has the injection sites reversed. I chose to have the flu shot in my left arm and the TDAP in my right arm.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in November 2018, between 02-NOV-2018 and 16-NOV-2018, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (Oka/Merck) subcutaneously (dose was not provided, lot# R017945, expiration date 24-JUN-2020) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. No adverse effect. The digital data logger was involved. The vaccine experienced temperature excursion between 15 degrees Fahrenheit to 46 degrees Fahrenheit (15.1 degrees Fahrenheit) for 1 hour. There were no previous temperature excursions. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1811USA009254: US-009507513-1811USA009255: US-009507513-1811USA009256: US-009507513-1811USA009258: US-009507513-1811USA009259: US-009507513-1811USA009260: US-009507513-1811USA009261: US-009507513-1811USA009142.
Patient reports after 1st moderna vaccine, 8 minutes later she experienced tremors and felt disoriented and her fingers turned blue. Went ot ed where she was diagnosed with panic attack. Symptoms ahd resolved and she was discharged home. She got her second vaccine on 4/8 and that night became very disoriented and acting odd (crawling around) and then became pale and was speaking incoherently. Was taken to ED where she had normal CBC, CMP, CT brain and CXR and then discharged home with dx of panic attack. Over the next day she felt much better and feels back to her normal self.
Patient began to experience pain a few hours after the vaccine was given. Called pharmacy 3 to 4 days later complaining about the pain and should it last that long. Pharmacist consulted patient and suggested to use Tylenol or Ibuprofen for pain and discomfort. The patient called a week later still experiencing similar pain. The Pharmacist suggested the patient follow up with a medical doctor to evaluate the arm and pain.
Breakthrough case admission after 2 vaccines Moderna 1/22/21 Lot# 029L20A;  Moderna 2/19/21 Lot# 023M20A
Rash all over the body after 31 hours of injection; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8733) via an unspecified route of administration in the left arm on 01Apr2021 at 10:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and triglycerides high from an unspecified date. The patient had no known allergies. Concomitant medications included fenofibrate (MANUFACTURER UNKNOWN) 160 mg tablet, amlodipine (MANUFACTURER UNKNOWN) 2.5 mg tablet all from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm left on 12Mar2021 at 17:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 17:30 the patient experienced Rash all over the body after 31 hours of injection. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event rash all over the body after 31 hours of injection was not resolved.   No follow-up attempts are needed; no further information is expected.
Increased temperature leading to seizure.  Temp 104.1 at Hospital Emergency Room.  Transferred via ambulance to another Hospital.  9/1/09 ER records received DOS 8/18/09. Assessment: Seizure, fever. Patient lethargic, seizure on way to ER. Presents with fever, tachycardia, lips blue, skin hot, crying. Transferred to another facility.  10/5/09 Received D/C Summary for DOS 8/18-8/20/2009. FINAL DX: complex febrile seizure; febrile illness, suspect viral syndrome. Patient experienced febrile seizure lasting approx 10 min followed by shorter episode of leg twitching.  Continued w/fever in hospital w/focal shaking events lasting approx 1 min each.
gave PROQUAD to an adult patient; No additional AE reported; This spontaneous report was received from other health professional and refers to an adult patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose, dosage regimen, lot #, expiry date, anatomical location, and route of administration were not provided) as prophylaxis (product administered to patient of inappropriate age). No adverse event was reported.
10/17/2022 - Multiple Bullous, erythematous Skin lesions started on right buttock, extend down back of thigh to posterior popliteal fossa. Seen at clinic and appearance of skin lesions consistent with shingles. No history of immunodeficiency or autoimmune disease. Had similar type of skin lesions before multiple times, but much milder/smaller in size. This was the most severe outbreak so far.
Information has been received from a registered nurse concerning a 5 year old female pt with recent varicella exposure who on 05/23/1997 was vaccinated with varicella vaccine. On 06/14/2001 the pt presented to the physician's office with a mild case of chicken pox with 8-10 lesions mostly on her trunk. It was noted that the pt was afebrile. It was reported that the pt had been exposed to another child with chicken pox two weeks ago who was also reported to have had been vaccinated with varicella vaccine at some time, but specifics were not known. It was indicated that pt sought medical attention. Additional info has been requested.
whole body hurts; terrible headache; A spontaneous report was received from a consumer concerning a 80-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed headache and body pains.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, was not reported.  On 15 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 16 Jan 2021, the patient developed headache and body pains. Treatment for the event was not reported.  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of the event, headache and body pains, was considered unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Screaming episodes day & night for 2-3h stopped crawling; pulls at face & head, increased temp, highest 104 degrees, intermittent, stopped eating solids x 1 wk.
Throat itchy, felt like right side of throat swelling, dizzy, skin hot.  Seen by doctor in vaccine clinic who held me for one hour.  Took Benadryl which helped reduce throat itching and feeling of swelling in throat.
Vesicular eruption quickly progressing (few days) to shallow ulcerations, rapidly healing located in 2-3cm area of right mid-forehead. No other lesions or periorbital/ocular findings. No fever. Examined by the physician on day 4 of course.
She said she experienced rapid heartbeat; Anxiety problems; She felt like she almost had a heart attack; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (She said she experienced rapid heartbeat), ANXIETY (Anxiety problems), FEELING ABNORMAL (She felt like she almost had a heart attack) and DIZZINESS (Dizziness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 020B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Her whole household have acquired COVID-19 so that she was really scared and worried about it) in March 2020. Concurrent medical conditions included Sulfonamide allergy (She had an allergic reaction to sulfur medication).   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (She said she experienced rapid heartbeat), ANXIETY (Anxiety problems), FEELING ABNORMAL (She felt like she almost had a heart attack) and DIZZINESS (Dizziness). At the time of the report, TACHYCARDIA (She said she experienced rapid heartbeat), ANXIETY (Anxiety problems), FEELING ABNORMAL (She felt like she almost had a heart attack) and DIZZINESS (Dizziness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: hightened (High) She also experienced heightened level of cholesterol. On an unknown date, Heart rate: rapid (High) She experienced rapid heart beat. On an unknown date, Oxygen consumption: low (Low) Low blood oxygen.         No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-406934 (Patient Link).
Intense pain at the site of injection and stiffness in RT shoulder area. As time went on pain increased and shoulder "froze"--could not be moved without excruciating pain. Ice helped the pain somewhat. After 24 hours of continuing negative progression began taking BENADRYL and Acetaminophen 500 mg. This made me so sleepy I could not stay up so went to bed and slept. Would wake up about every 5 hrs and repeated meds. 24 hrs after injection a red rash began on the upper arm near the shoulder joint. Continued taking BENADRYL and rash began fading after 24 hrs on med. Mild headache eventually set in and nightmares while sleeping. 6 days later arm is still slightly sore when moved or try to lift something heavy. Headache is better but still feel foggy--have stopped BENADRYL but continue Acetaminophen once daily. I did call urgent care and was told this is "normal" even though the paperwork the Dr office gave me said it is not and to call my doctor if these things happened. Heat has helped relax the shoulder. General over-all achiness is slowly dissipating.
Itching at injection site, given 2 tablets of 25mg diphenhydramine, symptoms improved after 10-15 minutes
March 19th, next morning after shot, headache and low grade fever up to 100.5.  Brain fog.  Fever subsided 48 hours later on the 20th.  Brain fog continued. Then, one week later, on March 25, headache and fever (between 100.0 - 100.7) and significant brain fog returned, lasting 5 days. fever broke on march 29th.
Pt recv vax on 4/8/99; 1/2 hr post vax pt exp red face w/ swelling & cough; tx=SC Epi & PO Benadryl
Information has been received from a physician concerning an unspecified patient. On an unknown date the patient inadvertently received his/her (it was also reported as their) first dose of ROTATEQ (2 ml, once, orally, strength and lo# were not reported) at aged five months. No adverse effects were reported. Additional information has been requested.
lt arm became sore that noc;saturday morning lt arm was sore, red & swollen & pt was running a temp around 101 to 101.6;arm was still red & swollen;